30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Soparkar Peter

Insider profile

Performance

Overall performance
1.6

Performance over holding periods
4.2
30 days 90 days 120 days
Average return -25% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 67% Buy
34 71% Buy
47 69% Buy
Performance for realised trades
4.4
Average return -82%
Success rate 73%
Average holding period 220
Transactions 28
Soparkar Peter's trades of Adverum Biotechnologies Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-12-08 2025-12-05 PP Planned purchase
97,700 -32.4%
208.43
US$4,016,037
97,700 -32.4% 208.43 US$4,016,037
2025-05-16 2025-05-15 S Sale
57,512 -8.2%
132.64
US$3,576,312
57,512 -8.2% 132.64 US$3,576,312
2023-03-17 2023-03-15 PlS Planned sale
22,065 +14.4%
257.67
US$38,870
22,065 +14.4% 257.67 US$38,870
2022-09-21 2022-09-19 PlS Planned sale
13,305 -4.6%
1.07
US$14,232
13,305 -4.6% 1.07 US$14,232
2022-04-20 2022-04-19 B Purchase
21,750 +8.4%
1.14
US$24,795
21,750 +8.4% 1.14 US$24,795
2022-04-20 2022-04-19 B Purchase
175 +0.1%
1.14
US$199
175 +0.1% 1.14 US$199
2021-12-10 2021-12-08 PP Planned purchase
25,000 +10.7%
1.91
US$47,750
25,000 +10.7% 1.91 US$47,750
2020-08-19 2020-08-17 PP Planned purchase
7,692 +256.4%
13.00
US$99,996
7,692 +256.4% 13.00 US$99,996